4//SEC Filing
ALIMERA SCIENCES INC 4
Accession 0001181431-13-063390
CIK 0001267602operating
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:30 PM ET
Size
7.7 KB
Accession
0001181431-13-063390
Insider Transaction Report
Form 4
Caballa Susan
SEE REMARKS
Transactions
- Award
Employee Stock Option (Right to Buy)
2013-12-16+90,000→ 90,000 totalExercise: $2.47Exp: 2023-12-15→ Common Stock (90,000 underlying) - Award
Employee Stock Option (Right to Buy)
2013-12-16+35,000→ 35,000 totalExercise: $2.47Exp: 2023-12-15→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]This option shall vest in forty-eight equal monthly installments beginning on January 16, 2014, provided that the Reporting Person remains continuously employed by the Issuer through each vesting period.
- [F2]This option shall become exercisable only upon approval by the U.S. Food and Drug Administration of the Issuer's New Drug Application for ILUVIEN(R) for the treatment of diabetic macular edema, provided that such approval occurs on or before December 31, 2014, in which case this option shall vest in forty-eight equal monthly installments beginning on January 16, 2014, provided further that the Reporting Person remains continuously employed by the Issuer through each vesting period.
Documents
Issuer
ALIMERA SCIENCES INC
CIK 0001267602
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001267602
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:30 PM ET
- Size
- 7.7 KB